EMCDDA Home
  • EN
Search

Table TDI-17. Route of administration by primary drug of clients entering treatment, 2009 or most recent year available [see all tables in this series...]

Part (v) New stimulants (other than cocaine) outpatient clients by country and usual route of administration (%)

CountryInjectSmoke/inhaleEat/drinkSniffOthersRoute known (n)Route unknown
Belgium10.31.719.468.60.035038
Bulgaria0.00.030.070.00.0100
Czech Republic 63.52.50.733.30.04086
Denmark1.60.015.582.90.019313
Germany:::::::
Estonia(1)70.020.010.00.00.0100
Ireland0.00.075.924.10.0541
Greece0.0100.00.00.00.010
Spain(2)0.62.942.653.70.335019
France0.03.277.416.13.2315
Italy4.50.095.50.00.011116
Cyprus0.0100.00.00.00.020
Latvia58.31.716.723.30.012027
Lithuania13.30.086.70.00.0150
Luxembourg :::::::
Hungary15.37.036.940.10.72874
Malta(3)100.00.00.00.00.040
Netherlands(4)0.92.121.175.90.033658
Austria0.04.231.364.60.0480
Poland(5)2.25.219.173.00.42304
Portugal:::::::
Romania0.00.0100.00.00.010
Slovenia0.00.050.050.00.040
Slovakia25.515.33.655.50.01376
Finland60.00.05.734.30.0352
Sweden29.64.052.812.80.81259
United Kingdom 15.02.172.98.41.6188167
Croatia0.00.025.075.00.0560
Turkey:::::::
Norway:::::::
Total17.02.944.934.40.84799275

Notes:

 : Indicates no data are available.                 

 Percentages are of clients whose route of administration is known (n) 

 (1) Data refers to outpatient and inpatient treatment centres (aggregated data). 

 (2) Data refer to 2008. Data refer to outpatient treatment centres and treatment units in prisons. 

 (3) Data refers to outpatient and inpatient treatment centres, low-threshold services and prisons (aggregated data).                 

 (4) Data refer to outpatient, inpatient and low-threshold agencies.                 

 (5) Data refers to 2008 and to 33 heatlh care units.                 

 See also 'General notes for interpreting data' on the Explanatory notes and help page

Sources:

 Reitox national reports 2010 — TDI — outpatient treatment centres. 

(see the help page for information about formats etc.)

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Thursday, 30 June 2011